ANI PHARMACEUTICALS INC·4

Apr 13, 4:40 PM ET

Cook Meredith 4

4 · ANI PHARMACEUTICALS INC · Filed Apr 13, 2026

Research Summary

AI-generated summary of this filing

Updated

ANI Pharmaceuticals Meredith Cook (Sr. VP, GC & Sec) Sells 500 Shares

What Happened Meredith Cook, Senior Vice President, General Counsel and Secretary of ANI Pharmaceuticals (ANIP), sold 500 shares on April 13, 2026. The shares were sold at $77.95 per share for a total transaction value of $38,975. This was a sale (not a purchase), and the filing notes the sale was executed pursuant to a Rule 10b5-1 trading plan.

Key Details

  • Transaction date and price: April 13, 2026 — 500 shares at $77.95 each.
  • Total value: $38,975.
  • Method: Reported as an open-market or private sale; footnote confirms it was effected under a 10b5-1 trading plan adopted September 15, 2025.
  • Shares owned after transaction: Not disclosed in the provided Form 4.
  • Filing timeliness: Report filed the same day (period and filing date 2026-04-13); no late filing indicated.

Context

  • Sales under a pre-established 10b5-1 plan are typically automatic and scheduled, so they do not necessarily signal a change in the insider’s view of the company. This report documents a routine insider sale rather than a purchase or option exercise.

Insider Transaction Report

Form 4
Period: 2026-04-13
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Transactions
  • Sale

    Common Stock

    [F1]
    2026-04-13$77.95/sh500$38,97578,890 total
Footnotes (1)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
Signature
/s/ Meredith W. Cook|2026-04-13

Documents

1 file
  • 4
    wk-form4_1776112832.xmlPrimary

    FORM 4